Karl Axel Staffan Eriksson
Oprichter bij Alertix Veterinary Diagnostics AB
Profiel
Karl Axel Staffan Eriksson is the founder of two companies.
He founded AroCell AB in 2003 and served as the Chief Scientific Officer from 2020 to 2021.
He also founded Alertix Veterinary Diagnostics AB in 2017 and currently holds the title of Director, Vice President-Research & Development.
Dr. Eriksson's former job was as a Professor at the Swedish University of Agricultural Sciences from 2000 to 2012.
Dr. Eriksson holds a doctorate degree from both Karolinska Institutet and the Swedish University of Agricultural Sciences.
Actieve functies van Karl Axel Staffan Eriksson
| Bedrijven | Functie | Begin |
|---|---|---|
Alertix Veterinary Diagnostics AB
 Alertix Veterinary Diagnostics AB Medical SpecialtiesHealth Technology Alertix Veterinary Diagnostics AB engages in developing and marketing of an assay for early detection and monitoring of cancer diseases in pets. Its products include Alertix Canine, Alertix Feline and Alertix Equine. The company was founded by Bengt Helge Emil Astrand, Karl Axel Staffan Eriksson and Saga Anne-Charlotte Aronsson in 2017 and is headquartered in Kalmar, Sweden. | Oprichter | 01-01-2017 |
Eerdere bekende functies van Karl Axel Staffan Eriksson
| Bedrijven | Functie | Einde |
|---|---|---|
| AROCELL AB | Oprichter | 01-01-2020 |
| Swedish University of Agricultural Sciences | Corporate Officer/Principal | - |
Opleiding van Karl Axel Staffan Eriksson
| Swedish University of Agricultural Sciences | Doctorate Degree |
| Karolinska Institutet | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AROCELL AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Alertix Veterinary Diagnostics AB
Alertix Veterinary Diagnostics AB Medical SpecialtiesHealth Technology Alertix Veterinary Diagnostics AB engages in developing and marketing of an assay for early detection and monitoring of cancer diseases in pets. Its products include Alertix Canine, Alertix Feline and Alertix Equine. The company was founded by Bengt Helge Emil Astrand, Karl Axel Staffan Eriksson and Saga Anne-Charlotte Aronsson in 2017 and is headquartered in Kalmar, Sweden. | Health Technology |
